Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues
Details for Australian Patent Application No. 2006233675 (hide)
International Classifications
Event Publications
6 December 2007 PCT application entered the National Phase
PCT publication WO2006/108627 Priority application(s): WO2006/108627
10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006233688-Phenylacetamides suitable as protein kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser